SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revance Therapeutics, Inc. – ‘10-K’ for 12/31/15 – ‘XML’

On:  Friday, 3/4/16, at 4:47pm ET   ·   For:  12/31/15   ·   Accession #:  1479290-16-31   ·   File #:  1-36297

Previous ‘10-K’:  ‘10-K’ on 3/4/15 for 12/31/14   ·   Next:  ‘10-K’ on 2/28/17 for 12/31/16   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/04/16  Revance Therapeutics, Inc.        10-K       12/31/15   99:11M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.44M 
 4: EX-10.27    Material Contract                                   HTML     34K 
 5: EX-10.28    Material Contract                                   HTML     29K 
 6: EX-10.31    Material Contract                                   HTML     76K 
 7: EX-10.34    Material Contract                                   HTML     57K 
 2: EX-10.6     Material Contract                                   HTML     74K 
 3: EX-10.8     Material Contract                                   HTML     80K 
 8: EX-21.1     Subsidiaries List                                   HTML     26K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     28K 
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
11: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
13: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
20: R1          Document and Entity Information                     HTML     56K 
21: R2          Consolidated Balance Sheets                         HTML    104K 
22: R3          Consolidated Balance Sheets (Parenthetical)         HTML     55K 
23: R4          Consolidated Statements of Operations and           HTML     95K 
                Comprehensive Loss                                               
24: R5          Consolidated Statements of Changes in Convertible   HTML    207K 
                Preferred Stock and of Stockholders? Equity                      
                (Deficit)                                                        
25: R6          Consolidated Statements of Changes in Convertible   HTML     37K 
                Preferred Stock and of Stockholders? Equity                      
                (Deficit) (Parenthetical)                                        
26: R7          Consolidated Statements of Cash Flows               HTML    194K 
27: R8          The Company and Basis of Presentation               HTML     47K 
28: R9          Summary of Significant Accounting Policies          HTML     81K 
29: R10         Revenue and License Agreements                      HTML     36K 
30: R11         Medicis Settlement                                  HTML     42K 
31: R12         Cash Equivalents and Investments                    HTML     96K 
32: R13         Fair Value Measurements                             HTML     96K 
33: R14         Balance Sheet Components                            HTML     71K 
34: R15         Notes Payable                                       HTML     50K 
35: R16         Convertible Notes, Warrants, and Related            HTML     44K 
                Derivatives                                                      
36: R17         Interest Expense                                    HTML     61K 
37: R18         Commitments and Contingencies                       HTML     49K 
38: R19         Common Stock                                        HTML     46K 
39: R20         Convertible Preferred Stock                         HTML     31K 
40: R21         Warrants                                            HTML     37K 
41: R22         Net Income (Loss) per Share Attributable to Common  HTML     81K 
                Stockholders                                                     
42: R23         Stock Option Plan                                   HTML    288K 
43: R24         Income Taxes                                        HTML     94K 
44: R25         Defined Contribution Plan                           HTML     32K 
45: R26         Subsequent Events                                   HTML     32K 
46: R27         Quarterly Results of Operations (Unaudited)         HTML     85K 
47: R28         Summary of Significant Accounting Policies          HTML    145K 
                (Policies)                                                       
48: R29         Cash Equivalents and Investments (Tables)           HTML     94K 
49: R30         Fair Value Measurements (Tables)                    HTML     89K 
50: R31         Balance Sheet Components (Tables)                   HTML     71K 
51: R32         Notes Payable (Tables)                              HTML     33K 
52: R33         Interest Expense (Tables)                           HTML     59K 
53: R34         Commitments and Contingencies (Tables)              HTML     36K 
54: R35         Common Stock (Tables)                               HTML     44K 
55: R36         Net Income (Loss) per Share Attributable to Common  HTML     82K 
                Stockholders (Tables)                                            
56: R37         Stock Option Plan (Tables)                          HTML    263K 
57: R38         Income Taxes (Tables)                               HTML     83K 
58: R39         Quarterly Results of Operations (Unaudited)         HTML     84K 
                (Tables)                                                         
59: R40         The Company and Basis of Presentation - Additional  HTML     93K 
                Information (Detail)                                             
60: R41         Summary of Significant Accounting Policies          HTML     53K 
                (Details)                                                        
61: R42         Revenue and License Agreements (Details)            HTML     53K 
62: R43         Medicis Settlement - Additional Information         HTML     69K 
                (Detail)                                                         
63: R44         Cash Equivalents and Investments (Details)          HTML     51K 
64: R45         Cash Equivalents and Investments Remaining          HTML     36K 
                Contractual Maturities Available-for-Sale                        
                Securities (Details)                                             
65: R46         Fair Value Measurements - Schedule of Fair Value    HTML     60K 
                of Financial Instruments (Detail)                                
66: R47         Fair Value Measurements - Summary of Changes in     HTML     35K 
                Fair Value of Financial Instruments (Detail)                     
67: R48         Fair Value Measurements (Narrative) (Details)       HTML     30K 
68: R49         Balance Sheet Components - Additional Information   HTML     35K 
                (Detail)                                                         
69: R50         Balance Sheet Components - Schedule of Property     HTML     48K 
                and Equipment, Net (Detail)                                      
70: R51         Balance Sheet Components - Schedule of Prepaid      HTML     39K 
                Expenses and Other Current Assets (Detail)                       
71: R52         Balance Sheet Components - Schedule of Accruals     HTML     48K 
                and Other Current Liabilities (Detail)                           
72: R53         Notes Payable - Hercules Notes Payable (Detail)     HTML     62K 
73: R54         Notes Payable - Essex Capital Notes (Detail)        HTML     81K 
74: R55         Notes Payable - Summary of Aggregate Total Future   HTML     35K 
                Minimum Lease Payments under the Financing                       
                Obligation (Detail)                                              
75: R56         Convertible Notes, Warrants, and Related            HTML    112K 
                Derivatives - Additional Information (Detail)                    
76: R57         Interest Expense - Summary of Interest Expense by   HTML     49K 
                Cash and Non-Cash Components (Detail)                            
77: R58         Commitments and Contingencies - Additional          HTML     49K 
                Information (Detail)                                             
78: R59         Commitments and Contingencies - Schedule of Future  HTML     45K 
                Minimum Lease Payments under Non-Cancelable                      
                Operating Leases (Detail)                                        
79: R60         Common Stock - Additional Information (Detail)      HTML     50K 
80: R61         Convertible Preferred Stock - Additional            HTML     37K 
                Information (Detail)                                             
81: R62         Warrants - Additional Information (Detail)          HTML     98K 
82: R63         Net Income (Loss) per Share Attributable to Common  HTML     80K 
                Stockholders - Schedule of Computation of Basic                  
                and Diluted Net Income (Loss) Per Share                          
                Attributable to Common Stockholders (Detail)                     
83: R64         Net Income (Loss) per Share Attributable to Common  HTML     45K 
                Stockholders - Summary of Common Stock Equivalents               
                Excluded from Computation of Diluted Net Income                  
                (Loss) Per Share (Detail)                                        
84: R65         Stock Option Plan - Additional Information          HTML    127K 
                (Detail)                                                         
85: R66         Stock Option Plan - Summary of Stock Option and     HTML    146K 
                Restricted Stock Award Activity (Details)                        
86: R67         Stock Option Plan - Stock Options Outstanding and   HTML     78K 
                Exercisable (Details)                                            
87: R68         Stock Option Plan - Summary of Restricted Stock     HTML     58K 
                Award Activity (Details)                                         
88: R69         Stock Option Plan - Fair Value Assumptions          HTML     48K 
                (Details)                                                        
89: R70         Stock Option Plan - Schedule of Stock-based         HTML     37K 
                Compensation Expense (Details)                                   
90: R71         Income Taxes - Additional Information (Detail)      HTML     61K 
91: R72         Income Taxes - Deferred Tax Assets and Liabilities  HTML     54K 
                (Details)                                                        
92: R73         Income Taxes - Effective Tax Rate Reconciliation    HTML     50K 
                (Details)                                                        
93: R74         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     38K 
94: R75         Defined Contribution Plan - Additional Information  HTML     29K 
                (Details)                                                        
95: R76         Subsequent Events - Additional Information          HTML     51K 
                (Details)                                                        
96: R77         Quarterly Results of Operations (Unaudited) -       HTML     52K 
                Additional Information (Details)                                 
98: XML         IDEA XML File -- Filing Summary                      XML    169K 
97: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K 
14: EX-101.INS  XBRL Instance -- rvnc-20151231                       XML   3.05M 
16: EX-101.CAL  XBRL Calculations -- rvnc-20151231_cal               XML    259K 
17: EX-101.DEF  XBRL Definitions -- rvnc-20151231_def                XML    757K 
18: EX-101.LAB  XBRL Labels -- rvnc-20151231_lab                     XML   2.19M 
19: EX-101.PRE  XBRL Presentations -- rvnc-20151231_pre              XML   1.23M 
15: EX-101.SCH  XBRL Schema -- rvnc-20151231                         XSD    225K 
99: ZIP         XBRL Zipped Folder -- 0001479290-16-000031-xbrl      Zip    302K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.3.1.900 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 346 </ContextCount>
<ElementCount> 446 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 97 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 8 </UnitCount>
<MyReports>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0001000 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 1001000 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 1002000 - Statement - Consolidated Statements of Operations and Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss </Role>
<ShortName> Consolidated Statements of Operations and Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 1003000 - Statement - Consolidated Statements of Changes in Convertible Preferred Stock and of Stockholders??? Equity (Deficit) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsOfChangesInConvertiblePreferredStockAndOfStockholdersEquityDeficit </Role>
<ShortName> Consolidated Statements of Changes in Convertible Preferred Stock and of Stockholders??? Equity (Deficit) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 1003001 - Statement - Consolidated Statements of Changes in Convertible Preferred Stock and of Stockholders??? Equity (Deficit) (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsOfChangesInConvertiblePreferredStockAndOfStockholdersEquityDeficitParenthetical </Role>
<ShortName> Consolidated Statements of Changes in Convertible Preferred Stock and of Stockholders??? Equity (Deficit) (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 1004000 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsOfCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 2101100 - Disclosure - The Company and Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CompanyAndBasisOfPresentation </Role>
<ShortName> The Company and Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 2102100 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryOfSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 2103100 - Disclosure - Revenue and License Agreements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueAndLicenseAgreements </Role>
<ShortName> Revenue and License Agreements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 2104100 - Disclosure - Medicis Settlement </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/MedicisSettlement </Role>
<ShortName> Medicis Settlement </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 2105100 - Disclosure - Cash Equivalents and Investments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsAndInvestments </Role>
<ShortName> Cash Equivalents and Investments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 2106100 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 2107100 - Disclosure - Balance Sheet Components </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponents </Role>
<ShortName> Balance Sheet Components </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 2108100 - Disclosure - Notes Payable </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/NotesPayable </Role>
<ShortName> Notes Payable </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 2109100 - Disclosure - Convertible Notes, Warrants, and Related Derivatives </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivatives </Role>
<ShortName> Convertible Notes, Warrants, and Related Derivatives </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 2110100 - Disclosure - Interest Expense </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/InterestExpense </Role>
<ShortName> Interest Expense </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 2111100 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 2112100 - Disclosure - Common Stock </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommonStock </Role>
<ShortName> Common Stock </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 2113100 - Disclosure - Convertible Preferred Stock </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConvertiblePreferredStock </Role>
<ShortName> Convertible Preferred Stock </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 2114100 - Disclosure - Warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Warrants </Role>
<ShortName> Warrants </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 2115100 - Disclosure - Net Income (Loss) per Share Attributable to Common Stockholders </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholders </Role>
<ShortName> Net Income (Loss) per Share Attributable to Common Stockholders </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 2116100 - Disclosure - Stock Option Plan </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlan </Role>
<ShortName> Stock Option Plan </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 2117100 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 2118100 - Disclosure - Defined Contribution Plan </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DefinedContributionPlan </Role>
<ShortName> Defined Contribution Plan </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 2119100 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 2120100 - Disclosure - Quarterly Results of Operations (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/QuarterlyResultsOfOperationsUnaudited </Role>
<ShortName> Quarterly Results of Operations (Unaudited) </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.revance.com/role/SummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 2305301 - Disclosure - Cash Equivalents and Investments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsAndInvestmentsTables </Role>
<ShortName> Cash Equivalents and Investments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/CashEquivalentsAndInvestments </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 2306301 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/FairValueMeasurements </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 2307301 - Disclosure - Balance Sheet Components (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponentsTables </Role>
<ShortName> Balance Sheet Components (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/BalanceSheetComponents </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 2308301 - Disclosure - Notes Payable (Tables) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/NotesPayableTables </Role>
<ShortName> Notes Payable (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/NotesPayable </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 2310301 - Disclosure - Interest Expense (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/InterestExpenseTables </Role>
<ShortName> Interest Expense (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/InterestExpense </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 2311301 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsAndContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/CommitmentsAndContingencies </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 2312301 - Disclosure - Common Stock (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommonStockTables </Role>
<ShortName> Common Stock (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/CommonStock </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 2315301 - Disclosure - Net Income (Loss) per Share Attributable to Common Stockholders (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholdersTables </Role>
<ShortName> Net Income (Loss) per Share Attributable to Common Stockholders (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholders </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 2316301 - Disclosure - Stock Option Plan (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanTables </Role>
<ShortName> Stock Option Plan (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/StockOptionPlan </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 2317301 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/IncomeTaxes </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 2320301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/QuarterlyResultsOfOperationsUnauditedTables </Role>
<ShortName> Quarterly Results of Operations (Unaudited) (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/QuarterlyResultsOfOperationsUnaudited </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 2401401 - Disclosure - The Company and Basis of Presentation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CompanyAndBasisOfPresentationAdditionalInformationDetail </Role>
<ShortName> The Company and Basis of Presentation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 2402402 - Disclosure - Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryOfSignificantAccountingPoliciesDetails </Role>
<ShortName> Summary of Significant Accounting Policies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/SummaryOfSignificantAccountingPoliciesPolicies </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 2403401 - Disclosure - Revenue and License Agreements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueAndLicenseAgreementsDetails </Role>
<ShortName> Revenue and License Agreements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/RevenueAndLicenseAgreements </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 2404401 - Disclosure - Medicis Settlement - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/MedicisSettlementAdditionalInformationDetail </Role>
<ShortName> Medicis Settlement - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 2405402 - Disclosure - Cash Equivalents and Investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsAndInvestmentsDetails </Role>
<ShortName> Cash Equivalents and Investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/CashEquivalentsAndInvestmentsTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 2405403 - Disclosure - Cash Equivalents and Investments Remaining Contractual Maturities Available-for-Sale Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsAndInvestmentsRemainingContractualMaturitiesAvailableForSaleSecuritiesDetails </Role>
<ShortName> Cash Equivalents and Investments Remaining Contractual Maturities Available-for-Sale Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 2406402 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Financial Instruments (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementsScheduleOfFairValueOfFinancialInstrumentsDetail </Role>
<ShortName> Fair Value Measurements - Schedule of Fair Value of Financial Instruments (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 2406403 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Financial Instruments (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfFinancialInstrumentsDetail </Role>
<ShortName> Fair Value Measurements - Summary of Changes in Fair Value of Financial Instruments (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 2406404 - Disclosure - Fair Value Measurements (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementsNarrativeDetails </Role>
<ShortName> Fair Value Measurements (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/FairValueMeasurementsTables </ParentRole>
<Position> 48 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 2407402 - Disclosure - Balance Sheet Components - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponentsAdditionalInformationDetail </Role>
<ShortName> Balance Sheet Components - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 2407403 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail </Role>
<ShortName> Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 2407404 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail </Role>
<ShortName> Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 2407405 - Disclosure - Balance Sheet Components - Schedule of Accruals and Other Current Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/BalanceSheetComponentsScheduleOfAccrualsAndOtherCurrentLiabilitiesDetail </Role>
<ShortName> Balance Sheet Components - Schedule of Accruals and Other Current Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 2408402 - Disclosure - Notes Payable - Hercules Notes Payable (Detail) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/NotesPayableHerculesNotesPayableDetail </Role>
<ShortName> Notes Payable - Hercules Notes Payable (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 53 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 2408403 - Disclosure - Notes Payable - Essex Capital Notes (Detail) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/NotesPayableEssexCapitalNotesDetail </Role>
<ShortName> Notes Payable - Essex Capital Notes (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 2408404 - Disclosure - Notes Payable - Summary of Aggregate Total Future Minimum Lease Payments under the Financing Obligation (Detail) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/NotesPayableSummaryOfAggregateTotalFutureMinimumLeasePaymentsUnderFinancingObligationDetail </Role>
<ShortName> Notes Payable - Summary of Aggregate Total Future Minimum Lease Payments under the Financing Obligation (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 2409401 - Disclosure - Convertible Notes, Warrants, and Related Derivatives - Additional Information (Detail) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivativesAdditionalInformationDetail </Role>
<ShortName> Convertible Notes, Warrants, and Related Derivatives - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 2410402 - Disclosure - Interest Expense - Summary of Interest Expense by Cash and Non-Cash Components (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/InterestExpenseSummaryOfInterestExpenseByCashAndNonCashComponentsDetail </Role>
<ShortName> Interest Expense - Summary of Interest Expense by Cash and Non-Cash Components (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 2411402 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsAndContingenciesAdditionalInformationDetail </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 2411403 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments under Non-Cancelable Operating Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail </Role>
<ShortName> Commitments and Contingencies - Schedule of Future Minimum Lease Payments under Non-Cancelable Operating Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 59 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 2412402 - Disclosure - Common Stock - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommonStockAdditionalInformationDetail </Role>
<ShortName> Common Stock - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 2413401 - Disclosure - Convertible Preferred Stock - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConvertiblePreferredStockAdditionalInformationDetail </Role>
<ShortName> Convertible Preferred Stock - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 61 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 2414401 - Disclosure - Warrants - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/WarrantsAdditionalInformationDetail </Role>
<ShortName> Warrants - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 2415402 - Disclosure - Net Income (Loss) per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetail </Role>
<ShortName> Net Income (Loss) per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholdersTables </ParentRole>
<Position> 63 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 2415403 - Disclosure - Net Income (Loss) per Share Attributable to Common Stockholders - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Income (Loss) Per Share (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholdersSummaryOfCommonStockEquivalentsExcludedFromComputationOfDilutedNetIncomeLossPerShareDetail </Role>
<ShortName> Net Income (Loss) per Share Attributable to Common Stockholders - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Income (Loss) Per Share (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/NetIncomeLossPerShareAttributableToCommonStockholdersTables </ParentRole>
<Position> 64 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 2416402 - Disclosure - Stock Option Plan - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanAdditionalInformationDetail </Role>
<ShortName> Stock Option Plan - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 2416403 - Disclosure - Stock Option Plan - Summary of Stock Option and Restricted Stock Award Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanSummaryOfStockOptionAndRestrictedStockAwardActivityDetails </Role>
<ShortName> Stock Option Plan - Summary of Stock Option and Restricted Stock Award Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 66 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 2416404 - Disclosure - Stock Option Plan - Stock Options Outstanding and Exercisable (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanStockOptionsOutstandingAndExercisableDetails </Role>
<ShortName> Stock Option Plan - Stock Options Outstanding and Exercisable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 67 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 2416405 - Disclosure - Stock Option Plan - Summary of Restricted Stock Award Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanSummaryOfRestrictedStockAwardActivityDetails </Role>
<ShortName> Stock Option Plan - Summary of Restricted Stock Award Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 68 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 2416406 - Disclosure - Stock Option Plan - Fair Value Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanFairValueAssumptionsDetails </Role>
<ShortName> Stock Option Plan - Fair Value Assumptions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 69 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 2416407 - Disclosure - Stock Option Plan - Schedule of Stock-based Compensation Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockOptionPlanScheduleOfStockBasedCompensationExpenseDetails </Role>
<ShortName> Stock Option Plan - Schedule of Stock-based Compensation Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 70 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 2417402 - Disclosure - Income Taxes - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesAdditionalInformationDetail </Role>
<ShortName> Income Taxes - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 71 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 2417403 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails </Role>
<ShortName> Income Taxes - Deferred Tax Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 72 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 2417404 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails </Role>
<ShortName> Income Taxes - Effective Tax Rate Reconciliation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 73 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 2417405 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails </Role>
<ShortName> Income Taxes - Unrecognized Tax Benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 74 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 2418401 - Disclosure - Defined Contribution Plan - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DefinedContributionPlanAdditionalInformationDetails </Role>
<ShortName> Defined Contribution Plan - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 75 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 2419401 - Disclosure - Subsequent Events - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SubsequentEventsAdditionalInformationDetails </Role>
<ShortName> Subsequent Events - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 76 </Position>
</Report>
<Report instance="rvnc-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 2420402 - Disclosure - Quarterly Results of Operations (Unaudited) - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/QuarterlyResultsOfOperationsUnauditedAdditionalInformationDetails </Role>
<ShortName> Quarterly Results of Operations (Unaudited) - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/QuarterlyResultsOfOperationsUnauditedTables </ParentRole>
<Position> 77 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> rvnc-20151231.xml </File>
<File> rvnc-20151231.xsd </File>
<File> rvnc-20151231_cal.xml </File>
<File> rvnc-20151231_def.xml </File>
<File> rvnc-20151231_lab.xml </File>
<File> rvnc-20151231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/23  Revance Therapeutics, Inc.        10-K       12/31/22  109:14M
 2/28/22  Revance Therapeutics, Inc.        10-K       12/31/21  106:12M
 2/25/21  Revance Therapeutics, Inc.        10-K       12/31/20  109:12M
 1/29/21  Revance Therapeutics, Inc.        S-8         1/29/21    3:137K
11/09/20  Revance Therapeutics, Inc.        10-Q        9/30/20   83:8.3M
↑Top
Filing Submission 0001479290-16-000031   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 1, 1:23:25.1pm ET